Last updated on April 2018

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.

Clinical Study Identifier: NCT02847624

Contact Investigators or Research Sites near you

Start Over

Drug Information Center

Otsuka Pharmaceutical Co., Ltd.
Tokyo, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.